HighLife hits series B round
The LivaNova-backed mitral valve replacement system developer has collected $36.3m in a round that increased its funding to almost $57m altogether.
Innovaccer gets $35m funding injection
Microsoft’s M12 subsidiary led an extension that brought Innovaccer’s series B round to a $35m close, and the company’s overall funding to $51m.
Bolder Surgical performs $27m funding operation
Formerly known as JustRight, Bolder has raised fresh funding in a Providence Ventures-backed round and rebranded to expand beyond paediatric equipment.
Ciitizen records $17m series A round
Healthcare record management platform Ciitzen has received $17m in an Andreessen Horowitz-led round that included participation from Alphabet subsidiary Verily.
Corporate venturing deal net: 14-18 January 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Mayo Clinic and ASU fuel MedTech Accelerator
The accelerator is open to medical device and healthtech businesses that have already amassed $500,000 of capital or are generating revenues.
Tyto Care collects $9m series C extension
Investors including Sanford Health and Itochu have added $9m to a series C round for the medical examination technology developer that now stands at $33.5m.
Trice Medical traverses series C extension
The orthopaedic diagnostics equipment developer has added $18.5m to a series C round featuring Smith & Nephew that now stands at $37.6m.

Other News

Vast Therapeutics inhales $15m
The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .
Cirius seeks entry to public markets
Novo-backed Cirius Therapeutics, which was supported at launch by Metabolic Solutions Development Company, will put the IPO proceeds into its lead liver disease treatment.
Von Tobel leaves NM to start Inspired Capital
NM Future Ventures alumni Alexa von Tobel and Mark Batsiyan have launched Inspired Capital, a venture capital firm aiming to raise $200m for its debut fund.
Mitsui helps Napajen nab series C funding
P&E Directions has joined existing investor Mitsui in a $12.4m round that increased the immunotherapy developer's total funding to more than $37m.
Beta Bionics bets on corporates in $63m round
Zealand and Dexom has contributed to a $13m extension to the artificial pancreas developer's series B round, which also includes Novo Nordisk.
Medbanks checks in series D funding
Tencent and CLP Fund helped provide $58.8m of funding for the cancer data platform developer, whose early investors include Ping An.

Editor's Picks

CVC in 2018 - The Trends: Part Two
In the second half of our guide to corporate venturing's biggest trends in 2018, we look at the growth of Chinese tech companies, genomics, advances in transport tech and the growth of the scooter rental space.
Relay Therapeutics runs away with $400m
SoftBank Vision Fund led a series B round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.
Zymergen climbs to $400m series C
The molecular product technology provider followed a nine-figure, SoftBank-led round two years ago with a series C led by the corporate's Vision Fund.
Moderna models $500m IPO filing
Merck & Co, AstraZeneca and Alexion are all in line for exits after Moderna Therapeutics, valued at $7.5bn earlier this year, filed for its initial public offering.
test reg